Key goals for building on 30 years of HIV/AIDS research

	Tweet

In the 30 years since the first reported cases of a mysterious illness now known as AIDS, researchers have made extraordinary advances in understanding, treating and preventing the disease. Now the challenge, according to experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is to build on those successes to control and, ultimately, end the HIV/AIDS pandemic.

In an article published online today by the Annals of Internal Medicine, Anthony S. Fauci, M.D., NIAID Director, and Carl W. Dieffenbach, Ph.D., Director of the NIAID Division of AIDS, discuss three research and implementation goals they believe are key to successfully achieving the long-term objective of ending the HIV/AIDS pandemic:

* Efficiently identify greater numbers of HIV-infected people earlier in the course of their disease through expanded voluntary HIV testing programs, and link them to appropriate care and antiretroviral treatment
* Find innovative approaches to curing HIV/AIDS by eradicating or permanently suppressing the virus in infected people, thereby eliminating the need for lifelong antiretroviral therapy
* Scale-up implementation of proven HIV prevention strategies, develop additional effective prevention strategies, such as a vaccine, and build on current successes in pre-exposure prophylaxis, microbicides and treatment-as-prevention to achieve a sustainable and comprehensive, combination HIV prevention strategy

In their paper, the authors explore the challenges and opportunities associated with each of these goals, noting that an integrated strategy combining a variety of effective public health tools is needed to successfully curb HIV/AIDS in the future.

###

ARTICLE: CW Dieffenbach and AS Fauci. Thirty years of HIV and AIDS: Future challenges and opportunities. Annals of Internal Medicine (2011).

NIAID Director Anthony S. Fauci, M.D., is available to discuss the article.

CONTACT: To schedule interviews, please contact Nalini Padmanabhan, (301) 402-1663, .

NIAID conducts and supports research - at NIH, throughout the United States, and worldwide - to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses.

About the National Institutes of Health (NIH): NIH, the nation’s medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases.

###

Contact: Nalini Padmanabhan

301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

RELATED STORIES:
FDA Advisory Panel Approves Home HIV Test Kit   FDA Approves New In-Home HIV Test   Home HIV test advances   Survey Reveals Support for Over-the Counter HIV Testing   F.D.A. Panel Weighs Preventive Use of H.I.V. Drug   Stem Cell Therapy Shows Promise in Fight Against HIV   Progress against HIV thwarted by patients’ unmet needs   California to test pill for HIV prevention   Mechanism of HIV spread has potential for future drug therapy   Seeking HIV treatment clues in the neem tree   HIV Prevention Pill’s Value Varies by Target   Using AIDS drugs to prevent infection: a bargain?

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]